In the Phase III studies LINC 3 and LINC 4, osilodrostat was effective and well tolerated in patients of Asian and non-Asian origin with Cushing's disease

Akira Shimatsu,Beverly M. K. Biller,Maria Fleseriu,Rosario Pivonello, Lee Eun Jig, Rattana Leelawattana,Kim Jung Hee,Rama Walia,Yerong Yu, Zhihong Li, Andrea Piacentini, Alberto M Pedroncelli,Peter J. Snyder

Endocrine Abstracts（2023）

引用 0|浏览1

暂无评分

摘要

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

查看译文

关键词

cushing,osilodrostat,phase iii studies linc,non-asian

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要